High Level Disinfection Services Market size was more than USD 31.6 billion in 2026 and is set to grow at a 6.94% CAGR between 2027 and 2036, reaching USD 61.81 billion by 2036. The industry revenue for 2027 is assessed at USD 33.45 billion.
Rising concern over hospital-acquired infections is increasing demand in the high level disinfection services market as healthcare facilities place greater emphasis on preventing pathogen transmission through reusable medical equipment and clinical environments. Effective high-level disinfection is particularly important for equipment that comes into contact with patients and requires thorough decontamination before reuse. Healthcare providers are strengthening infection-control procedures to reduce contamination risks, improve patient safety, and maintain compliance with established clinical protocols. This heightened focus on infection prevention encourages facilities to adopt systematic and specialized disinfection processes for equipment and areas where inadequate sterilization could create significant healthcare risks.
A growing chronic disease burden is contributing to higher healthcare utilization, increasing the volume of diagnostic procedures, treatments, surgeries, and other interventions that require properly disinfected medical equipment. The high level disinfection services market benefits from this sustained clinical activity because repeated use of reusable devices creates ongoing requirements for reliable decontamination between procedures. Patients with chronic conditions may also require recurring medical interventions, increasing equipment turnover across hospitals, clinics, and specialized care facilities. As healthcare providers manage greater patient volumes and more frequent procedures, maintaining consistent disinfection practices becomes an important component of infection-control operations.
Outsourcing sterilization and disinfection activities to specialized service providers is enabling healthcare facilities to access dedicated expertise while reducing the operational burden associated with managing complex decontamination processes internally. The high level disinfection services market is supported by this trend as hospitals seek service partners capable of applying standardized procedures, maintaining appropriate equipment, and supporting infection-control requirements. External providers can help healthcare organizations manage specialized workflows without requiring them to commit extensive internal resources to disinfection infrastructure and personnel training. This approach can also allow clinical staff to focus more closely on patient care while specialized teams handle equipment processing and related disinfection activities.
| Growth Driver Assessment Framework | |||||
| Growth Driver | Impact On CAGR | Regulatory Influence | Geographic Relevance | Adoption Rate | Impact Timeline |
|---|---|---|---|---|---|
| Rising hospital-acquired infections increasing demand for strict healthcare disinfection protocols | 2.20% | High | North America, Asia Pacific | High | Near Term |
| Growing chronic disease burden driving higher healthcare facility utilization and sterilization needs | 1.70% | High | Global | High | Mid Term |
| Outsourcing of sterilization services to specialized providers improving hospital operational efficiency | 1.00% | Moderate | North America, Europe | Medium | Mid Term |
In the high level disinfection services market, North America held the largest share of 38.12% in 2026, supported by advanced healthcare infrastructure, strong infection prevention practices, and widespread use of sophisticated medical equipment. Healthcare facilities place significant emphasis on maintaining stringent hygiene and sterilization standards, creating consistent demand for specialized disinfection services. The region’s established clinical environment, focus on patient safety, and adoption of increasingly complex reusable medical devices further support the need for reliable high-level disinfection processes.
Asia Pacific is experiencing the fastest growth in the high level disinfection services market as healthcare infrastructure expands and medical facilities increasingly strengthen infection control capabilities. Rising healthcare investment and modernization of hospitals are encouraging greater adoption of professional disinfection practices, particularly as facilities expand their use of advanced medical equipment. Growing awareness of healthcare-associated infection prevention and improving clinical standards are also supporting demand for specialized services across the region.
The U.S. healthcare sector is increasing reliance on specialized high level disinfection services to support infection prevention and regulatory compliance. Hospitals and outpatient facilities are seeking service providers that can manage growing volumes of reusable medical devices efficiently.
Japan is strengthening high level disinfection capabilities as healthcare systems manage rising procedure volumes and aging demographics. Service providers in Japan are investing in automated and quality-controlled processes to support safe reuse of complex medical instruments.
South Korea is adopting outsourced disinfection services to improve operational efficiency in hospitals and specialized clinics. Healthcare providers in South Korea increasingly value rapid turnaround times and advanced reprocessing methods that minimize infection risks.
Germany is emphasizing standardized reprocessing procedures and validated disinfection protocols across healthcare settings. Demand in Germany is supported by healthcare providers seeking consistent service quality and traceability in instrument decontamination practices.
France is reinforcing infection control practices through stringent disinfection requirements in healthcare facilities. Service providers in France are focusing on validated workflows and documentation systems that help institutions meet quality and patient safety expectations.
Italy is expanding access to high level disinfection services as hospitals modernize reprocessing capabilities and improve resource utilization. Demand in Italy is shaped by the need to maintain equipment availability while adhering to increasingly rigorous hygiene standards.
The hospitals & clinics segment dominated the high level disinfection services market in 2026 with a 42.39% share and is also positioned as the fastest-growing segment. Hospitals and clinics have a high concentration of reusable medical instruments and devices that require effective high-level disinfection to reduce the risk of healthcare-associated infections. Growing emphasis on infection prevention, stringent sterilization protocols, and the need to maintain patient safety are strengthening demand for professional disinfection services. Increasing procedural activity and the adoption of sophisticated medical equipment further support the segment, as healthcare facilities require reliable and standardized decontamination processes across operating rooms, diagnostic areas, and specialized care units.
The glutaraldehyde segment accounted for the largest share of the high level disinfection services market in 2026, representing 24.49% of the market. Its established use for disinfecting heat-sensitive medical instruments supports continued adoption, particularly where broad-spectrum antimicrobial activity and compatibility with reusable equipment are important. Familiarity among healthcare personnel, established handling procedures, and its application across a range of medical devices contribute to its strong market position.
Ortho-phthalaldehyde is emerging as the fastest-growing compound segment as healthcare providers increasingly seek high-level disinfectants that combine effective microbial control with practical processing characteristics. Its suitability for sensitive medical equipment and growing focus on efficient instrument reprocessing are supporting adoption. Increasing attention to worker safety, workflow efficiency, and consistent disinfection performance is also encouraging healthcare facilities to consider alternative compounds for advanced infection-control applications.
| Report Segmentation | |||
| Segment | Sub-Segment | Largest Segment | Fastest Growing Segment |
|---|---|---|---|
| End-use | Hospitals & Clinics, Diagnostic Laboratories, Pharmaceutical & Biotechnology Companies, Academic and Research Institutes, Others | Hospitals & Clinics | Hospitals & Clinics |
| Compound | Formaldehyde, Glutaraldehyde, Ortho-phthalaldehyde, Hydrogen Peroxide, Peracetic Acid, Others | Glutaraldehyde | Ortho-phthalaldehyde |
| Services | In House, Outsource | Outsource | In House |
1. STERIS plc (Ireland)
2. Fortive Corporation (United States)
3. Getinge AB (Sweden)
4. Ecolab Inc. (United States)
5. Olympus Corporation (Japan)
6. Steelco S.p.A. (Italy)
7. GE HealthCare Technologies Inc. (United States)
8. Metrex Research LLC (United States)
9. Rentokil Initial plc (United Kingdom)
10. Altapure LLC (United States)
Increasing infection prevention standards are strengthening the high level disinfection services market, encouraging the adoption of advanced sterilization technologies and standardized disinfection protocols. Regulatory compliance and improved healthcare safety practices continue to drive service innovation and operational quality.
| Company Name | Date | Key Development |
|---|---|---|
| Clorox | Apr-26 | Clorox completed the acquisition of GOJO Industries, integrating the Purell brand into its hygiene portfolio. The transaction significantly strengthened Clorox’s position across institutional and healthcare disinfection markets by expanding its presence in hand hygiene and surface sanitation solutions. |
| Diversey | Sep-24 | Diversey, a Solenis company, entered a strategic partnership with Synexis to distribute dry hydrogen peroxide microbial-reduction technology across healthcare customers in the United States and Canada. The collaboration expanded access to advanced non-liquid disinfection technologies within clinical and institutional hygiene environments. |
| Diversey | May-24 | Diversey launched Oxivir Three 64 for healthcare applications, while Ecolab introduced Disinfectant 1 Wipe, a 100% plastic-free EPA-registered hospital disinfection wipe. These developments reflect increasing industry adoption of peroxide-based chemistries and sustainable formats in infection prevention and surface disinfection solutions. |
| Ecolab | May-24 | Ecolab introduced Disinfectant 1 Wipe, an EPA-registered hospital-grade disinfection wipe designed with a fully plastic-free degradable substrate. The product supports institutional demand for rapid-action disinfection solutions while addressing growing sustainability requirements in healthcare cleaning and hygiene operations. |